Biovica International AB (publ)

OM:BIOVIC B Stock Report

Market Cap: SEK 157.0m

Biovica International Past Earnings Performance

Past criteria checks 0/6

Biovica International's earnings have been declining at an average annual rate of -35.3%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been declining at an average rate of 13.3% per year.

Key information

-35.3%

Earnings growth rate

-17.8%

EPS growth rate

Biotechs Industry Growth0.7%
Revenue growth rate-13.3%
Return on equity-129.2%
Net Margin-1,593.9%
Next Earnings Update13 Mar 2025

Recent past performance updates

Recent updates

Is Biovica International (STO:BIOVIC B) In A Good Position To Invest In Growth?

Dec 03
Is Biovica International (STO:BIOVIC B) In A Good Position To Invest In Growth?

Is Biovica International (STO:BIOVIC B) In A Good Position To Deliver On Growth Plans?

Jul 18
Is Biovica International (STO:BIOVIC B) In A Good Position To Deliver On Growth Plans?

Here's Why We're Watching Biovica International's (STO:BIOVIC B) Cash Burn Situation

Dec 02
Here's Why We're Watching Biovica International's (STO:BIOVIC B) Cash Burn Situation

Here's Why We're Not Too Worried About Biovica International's (STO:BIOVIC B) Cash Burn Situation

Aug 02
Here's Why We're Not Too Worried About Biovica International's (STO:BIOVIC B) Cash Burn Situation

Here's Why We're Not At All Concerned With Biovica International's (STO:BIOVIC B) Cash Burn Situation

Feb 17
Here's Why We're Not At All Concerned With Biovica International's (STO:BIOVIC B) Cash Burn Situation

A Look At The Intrinsic Value Of Biovica International AB (publ) (STO:BIOVIC B)

Jan 19
A Look At The Intrinsic Value Of Biovica International AB (publ) (STO:BIOVIC B)

Companies Like Biovica International (STO:BIOVIC B) Can Afford To Invest In Growth

Nov 11
Companies Like Biovica International (STO:BIOVIC B) Can Afford To Invest In Growth

We Think Biovica International (STO:BIOVIC B) Can Easily Afford To Drive Business Growth

Aug 06
We Think Biovica International (STO:BIOVIC B) Can Easily Afford To Drive Business Growth

We're Not Worried About Biovica International's (STO:BIOVIC B) Cash Burn

Mar 20
We're Not Worried About Biovica International's (STO:BIOVIC B) Cash Burn

Who Has Been Buying Biovica International AB (publ) (STO:BIOVIC B) Shares?

Feb 22
Who Has Been Buying Biovica International AB (publ) (STO:BIOVIC B) Shares?

What Kind Of Shareholders Hold The Majority In Biovica International AB (publ)'s (STO:BIOVIC B) Shares?

Jan 26
What Kind Of Shareholders Hold The Majority In Biovica International AB (publ)'s (STO:BIOVIC B) Shares?

The Biovica International (STO:BIOVIC B) Share Price Has Soared 349%, Delighting Many Shareholders

Dec 31
The Biovica International (STO:BIOVIC B) Share Price Has Soared 349%, Delighting Many Shareholders

Here's Why We're Not At All Concerned With Biovica International's (STO:BIOVIC B) Cash Burn Situation

Dec 05
Here's Why We're Not At All Concerned With Biovica International's (STO:BIOVIC B) Cash Burn Situation

Revenue & Expenses Breakdown

How Biovica International makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:BIOVIC B Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Jul 247-1151150
30 Apr 247-1251240
31 Jan 247-1231200
31 Oct 237-1241220
31 Jul 236-1221200
30 Apr 235-1101070
31 Jan 236-92890
31 Oct 225-78760
31 Jul 225-69670
30 Apr 225-60590
31 Jan 223-53520
31 Oct 214-50480
31 Jul 217-43450
30 Apr 217-39430
31 Jan 219-38420
31 Oct 2010-35400
31 Jul 2010-33380
30 Apr 2010-30350
31 Jan 2012-25330
31 Oct 1911-24320
31 Jul 1910-24300
30 Apr 1910-22280
31 Jan 1910-20250
31 Oct 189-20250
31 Jul 189-19240
30 Apr 1810-18240
31 Jan 189-20250
31 Oct 179-18230
31 Jul 178-16210
30 Apr 176-15190
31 Jan 176-11150
31 Oct 166-9140
31 Jul 167-7130
30 Apr 167-6120
30 Apr 154-7100
30 Apr 144-580

Quality Earnings: BIOVIC B is currently unprofitable.

Growing Profit Margin: BIOVIC B is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BIOVIC B is unprofitable, and losses have increased over the past 5 years at a rate of 35.3% per year.

Accelerating Growth: Unable to compare BIOVIC B's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BIOVIC B is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-18.2%).


Return on Equity

High ROE: BIOVIC B has a negative Return on Equity (-129.23%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 10:57
End of Day Share Price 2024/12/20 00:00
Earnings2024/07/31
Annual Earnings2024/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biovica International AB (publ) is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jakob LembkeABG Sundal Collier Sponsored
Dan AkschutiPareto Securities
Johan UnnerusRedeye